MX377225B - Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene. - Google Patents
Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene.Info
- Publication number
- MX377225B MX377225B MX2018007124A MX2018007124A MX377225B MX 377225 B MX377225 B MX 377225B MX 2018007124 A MX2018007124 A MX 2018007124A MX 2018007124 A MX2018007124 A MX 2018007124A MX 377225 B MX377225 B MX 377225B
- Authority
- MX
- Mexico
- Prior art keywords
- human milk
- hmo
- milk oligosaccharides
- composition containing
- synthetic mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 2
- LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 abstract 2
- LKOHREGGXUJGKC-GXSKDVPZSA-N alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp Chemical compound C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O LKOHREGGXUJGKC-GXSKDVPZSA-N 0.000 abstract 2
- HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
- AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 abstract 1
- WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 1
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 1
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 1
- 229940062780 lacto-n-neotetraose Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Pediatric Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Dairy Products (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Abstract
La presente invención se refiere a una composición para infantes o niños pequeños caracterizada porque comprende una mezcla sintética de oligosacáridos de la leche humana que consiste en lacto-N-neotetraosa, lacto-N-tetraosa, 2´-O-fucosillactosa, 3´-O-sialillactosda, 6´-O-sialillactosa y ya sea difucosillactosa o 3-fucosillactosa, preferentemente difucosillactosa, y opcionalmente lactosa.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15200067 | 2015-12-15 | ||
| EP16154144 | 2016-02-03 | ||
| PCT/EP2016/081308 WO2017103019A1 (en) | 2015-12-15 | 2016-12-15 | Mixture of hmos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018007124A MX2018007124A (es) | 2018-09-07 |
| MX377225B true MX377225B (es) | 2025-03-07 |
Family
ID=57543057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018007124A MX377225B (es) | 2015-12-15 | 2016-12-15 | Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene. |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US11432578B2 (es) |
| EP (2) | EP3389404B1 (es) |
| CN (3) | CN116059221A (es) |
| AU (2) | AU2016372446B2 (es) |
| BR (1) | BR112018010505B1 (es) |
| CL (1) | CL2018001549A1 (es) |
| ES (1) | ES2759556T3 (es) |
| MX (1) | MX377225B (es) |
| MY (1) | MY186217A (es) |
| PH (1) | PH12018501221A1 (es) |
| PT (1) | PT3389404T (es) |
| WO (2) | WO2017103850A1 (es) |
| ZA (1) | ZA201804691B (es) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160113952A1 (en) * | 2013-05-22 | 2016-04-28 | Glycom As | Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal |
| PT3389404T (pt) | 2015-12-15 | 2020-01-14 | Nestle Sa | Mistura de hmos |
| US20180103675A1 (en) * | 2016-10-14 | 2018-04-19 | Mead Johnson Nutrition Company | Personalized pediatric nutrition products comprising human milk oligosaccharides |
| MX2020007192A (es) * | 2017-12-01 | 2020-08-24 | Nestle Sa | Composicion fortificadora de leche humana. |
| CN111556755A (zh) * | 2017-12-05 | 2020-08-18 | 格礼卡姆股份公司 | 用于治疗偏头痛的人乳寡糖 |
| EP3494807A1 (en) * | 2017-12-11 | 2019-06-12 | Jennewein Biotechnologie GmbH | Spray-dried sialyllactose |
| EP3494804B1 (en) * | 2017-12-08 | 2025-08-13 | Chr. Hansen HMO GmbH | Spray-dried 3-fucosyllactose |
| EP3720300A1 (en) * | 2017-12-08 | 2020-10-14 | Jennewein Biotechnologie GmbH | Spray-dried tetrasaccharides |
| EP3494805B1 (en) * | 2017-12-08 | 2025-08-13 | Chr. Hansen HMO GmbH | Spray-dried tetrasaccharides |
| CN118452467A (zh) | 2017-12-22 | 2024-08-09 | 雀巢产品有限公司 | 用途是用于减少婴儿和幼儿的伤害感觉的组合物 |
| WO2020013683A1 (en) * | 2018-07-12 | 2020-01-16 | N.V. Nutricia | Nutritional composition for improving intestinal barrier integrity, preparation of the composition and method of treatment |
| BR112021011344A2 (pt) * | 2018-12-21 | 2021-08-31 | Glycom A/S | Composição e método para promoção de cura de barreira intestinal |
| WO2020126542A1 (en) * | 2018-12-21 | 2020-06-25 | Societe Des Produits Nestle S.A. | A nutritional composition comprising 6'sl and lnt in combination to improve the gastrointestinal barrier function |
| US20220079988A1 (en) * | 2018-12-21 | 2022-03-17 | Societe Des Produits Nestle S.A. | A nutritional composition comprising metabolites of hmos to improve the gastrointestinal barrier |
| US20220062311A1 (en) | 2018-12-21 | 2022-03-03 | Societe Des Produits Nestle S.A. | A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier |
| BE1027078A9 (nl) * | 2019-02-25 | 2020-09-28 | Nutribam Bvba | Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid |
| US20220022515A1 (en) | 2019-02-25 | 2022-01-27 | Nutribam Bv | Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health |
| EP3934657A4 (en) * | 2019-03-05 | 2023-01-04 | Glycom A/S | HUMAN MILK OLYGOSACCHARIDES TO IMPROVE EXECUTION FUNCTION |
| ES1240969Y (es) * | 2019-09-18 | 2020-07-30 | Jennewein Biotechnologie Gmbh | Composiciones de cereales que contienen oligosacaridos de la leche humana |
| CN112515170B (zh) * | 2019-11-29 | 2023-02-21 | 伊利伊诺科技(上海)有限责任公司 | 提高胃肠道免疫能力的乳双歧杆菌与益生元组合物及应用 |
| BR112022010061A2 (pt) * | 2019-11-29 | 2022-09-06 | Glycom As | Mistura de olhs para melhorar a microbiota das mulheres grávidas |
| CN112870233B (zh) * | 2019-11-29 | 2024-08-23 | 伊利伊诺科技(上海)有限责任公司 | 包含乳双歧杆菌与母乳低聚糖的组合物及其应用 |
| BR112022016589A2 (pt) * | 2019-12-06 | 2022-10-11 | Glycom As | Composição que compreende 2?-fl e dfl para uso em um método para reduzir a dor |
| US20220409645A1 (en) * | 2019-12-06 | 2022-12-29 | Societe Des Produits Nestle S.A. | Compositions for use in the reduction of pain and/or perception of pain in infants and young children |
| WO2021115990A1 (en) * | 2019-12-09 | 2021-06-17 | Société des Produits Nestlé S.A. | Compositions comprising human milk oligosaccharides for use in a subject to support language development |
| CN114786501A (zh) * | 2019-12-11 | 2022-07-22 | 雀巢产品有限公司 | 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物 |
| GB2590375B (en) * | 2019-12-11 | 2024-05-08 | Mjn Us Holdings Llc | Staged nutritional compositions containing human milk oligosaccharides and uses thereof |
| JP7516053B2 (ja) * | 2020-01-20 | 2024-07-16 | 森永乳業株式会社 | 組成物並びに飲食品組成物、栄養組成物および調製乳 |
| CN113519849B (zh) * | 2020-04-14 | 2023-04-07 | 内蒙古伊利实业集团股份有限公司 | 提升肠道对大肠杆菌感染的抵御力的母乳低聚糖及其应用 |
| CN112075637B (zh) * | 2020-04-27 | 2023-05-23 | 合生元（广州）健康产品有限公司 | 一种减少肠道气体产生的组合物 |
| EP4172191A1 (en) * | 2020-06-26 | 2023-05-03 | Société des Produits Nestlé S.A. | Serpin production |
| CN116261398A (zh) * | 2020-10-16 | 2023-06-13 | 雀巢产品有限公司 | 包含人乳低聚糖的营养组合物 |
| CN114431484A (zh) * | 2020-11-06 | 2022-05-06 | 内蒙古伊利实业集团股份有限公司 | 人乳寡糖在提高肠道对沙门氏菌感染抵御能力中的应用 |
| JP2023547175A (ja) * | 2020-11-10 | 2023-11-09 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 栄養組成物 |
| US20240000868A1 (en) * | 2020-11-16 | 2024-01-04 | Inner Mongolia Yili Industrial Group Co., Ltd. | Composition Containing Bifidobacterium Lactis and Human Milk Oligosaccharides and Application Thereof |
| US20240000122A1 (en) * | 2020-12-04 | 2024-01-04 | Societe Des Produits Nestle S.A. | Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration |
| AU2021403857A1 (en) * | 2020-12-18 | 2023-06-08 | Société des Produits Nestlé S.A. | Compositions for use in promoting accelerated butyrate production in young children |
| AU2021410690A1 (en) * | 2020-12-22 | 2023-08-10 | Intrinsic Medicine, Inc. | Immunomodulatory oligosaccharides for the enhancement of anti-tumor efficacy of immuno-oncology agents |
| EP4284193B1 (en) * | 2021-01-29 | 2025-05-07 | Société des Produits Nestlé S.A. | Mixture of hmos and bifidobacteria |
| WO2022254016A1 (en) | 2021-06-04 | 2022-12-08 | N.V. Nutricia | Infant formula for feeding infants receiving infant formula and human breast milk |
| WO2023066907A1 (en) | 2021-10-18 | 2023-04-27 | Dsm Ip Assets B.V. | A method for providing an amorphous hmo product by drying |
| CN114223723A (zh) * | 2021-12-13 | 2022-03-25 | 黑龙江飞鹤乳业有限公司 | 营养组合物、包含其的食品以及该营养组合物的用途 |
| DE102021134539A1 (de) | 2021-12-23 | 2023-06-29 | AASAYA LifeScience GmbH | Synbiotikum zur Anwendung in einem Therapieverfahren |
| WO2024064327A1 (en) * | 2022-09-22 | 2024-03-28 | Abbott Laboratories | Human milk oligosaccharides for enhancing blood-brain barrier function |
| CN116602409B (zh) * | 2023-02-20 | 2024-04-05 | 合生元（广州）健康产品有限公司 | 一种抑制轮状病毒感染的组合物 |
| WO2024223906A1 (en) * | 2023-04-28 | 2024-10-31 | Société des Produits Nestlé S.A. | Composition for use in a subject |
| WO2025008277A1 (en) * | 2023-07-06 | 2025-01-09 | Societe Des Produits Nestle S.A. | Combination for dietary management of gut health |
| CN118104826A (zh) * | 2023-12-29 | 2024-05-31 | 澳优乳业（中国）有限公司 | 一种用于改善神经发育和功能障碍的低聚糖组合物 |
| WO2025196272A1 (en) * | 2024-03-22 | 2025-09-25 | Dsm Ip Assets B.V. | Combination of mixtures of hmos with mfgm and their use |
| WO2025233455A1 (en) | 2024-05-08 | 2025-11-13 | N.V. Nutricia | Nutritional composition for strenghtening the gut barrier |
| CN119454723A (zh) * | 2024-10-17 | 2025-02-18 | 嘉必优生物技术（武汉）股份有限公司 | 母乳低聚糖在制备抑制肠道Ruminococcus增殖的制剂中的应用 |
| CN119138609B (zh) * | 2024-11-19 | 2025-02-25 | 飞鹤(吉林)乳品有限公司 | 母乳低聚糖改善母婴肠道菌群的用途 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0686684A (ja) | 1992-05-26 | 1994-03-29 | Monsanto Co | シアロ抱合体の合成 |
| US6045854A (en) | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
| FR2796082B1 (fr) | 1999-07-07 | 2003-06-27 | Centre Nat Rech Scient | Procede de production d'oligosaccharides |
| EP1629850B2 (en) | 2004-08-24 | 2013-05-22 | N.V. Nutricia | Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides |
| CN101415834B (zh) | 2006-03-09 | 2014-09-24 | 国家科学研究中心 | 生产涎化低聚糖的方法 |
| EP2060257A1 (en) | 2007-11-08 | 2009-05-20 | Nestec S.A. | Prevention and treatment of secondary infections following viral infection |
| CN101945589A (zh) | 2007-12-21 | 2011-01-12 | 荷兰纽迪希亚公司 | 用于改善肠道微生物群的非消化性碳水化合物的用途 |
| WO2010002241A1 (en) | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
| EP2342222B1 (en) | 2008-09-22 | 2018-03-21 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| CA2758097A1 (en) | 2009-04-07 | 2010-10-14 | Glycom A/S | Synthesis of 2'-o-fucosyllactose |
| RU2012140011A (ru) | 2010-02-19 | 2014-03-27 | Глюком А/С | Получение 6'-о-сиалиллактозы и промежуточные соединения |
| CN102803282A (zh) | 2010-02-19 | 2012-11-28 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
| EP2544539B1 (en) | 2010-03-12 | 2015-04-29 | DSM IP Assets B.V. | Maternal sialic acid supplementation |
| EP2454948A1 (en) * | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
| EP2465509A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating acute respiratory tract infections |
| MY180910A (en) * | 2010-12-31 | 2020-12-11 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
| BR112013016587A2 (pt) * | 2010-12-31 | 2016-09-27 | Abbott Lab | formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas |
| CA2822222C (en) * | 2010-12-31 | 2019-05-07 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
| MY166946A (en) * | 2010-12-31 | 2018-07-25 | Abbott Lab | Methods of using human milk oligosaccharides for improving airway respiratory health |
| MX355780B (es) * | 2010-12-31 | 2018-04-30 | Abbott Lab | Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal. |
| MX345413B (es) * | 2011-02-10 | 2017-01-27 | Nestec Sa | Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana. |
| BR112013029203A2 (pt) | 2011-05-13 | 2016-08-09 | Glycom As | método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano |
| CN103703012A (zh) | 2011-05-13 | 2014-04-02 | 格礼卡姆股份公司 | 乳糖-n-四糖的制造 |
| EP2525364A1 (en) | 2011-05-20 | 2012-11-21 | Areva NP | Nuclear fuel assembly having varying spacing between fuel rods |
| MX368124B (es) | 2011-08-29 | 2019-09-19 | Abbott Lab | Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal. |
| EP2760875A4 (en) * | 2011-09-30 | 2015-08-26 | Glycom As | SYNTHESIS OF HMO NUCLEAR STRUCTURES |
| MX350436B (es) | 2011-10-18 | 2017-09-06 | Nestec Sa | Composicion para uso en el aumento de sensibilidad a la insulina y/o la reduccion de resistencia a la insulina. |
| EP2775852B1 (en) * | 2011-10-18 | 2016-08-17 | Nestec S.A. | Composition for use in brain growth and/or cognitive and/or psychomotor development |
| WO2013091660A1 (en) | 2011-12-23 | 2013-06-27 | Glycom A/S | A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof |
| US20150065702A1 (en) | 2012-03-20 | 2015-03-05 | Glycom A/S | Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof |
| WO2013154725A1 (en) | 2012-04-13 | 2013-10-17 | Trustees Of Boston College | Prebiotic compositions and methods of use |
| US9896470B2 (en) * | 2012-06-14 | 2018-02-20 | Glycom A/S | Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or blends thereof |
| CN104883908A (zh) * | 2012-11-02 | 2015-09-02 | N·V·努特里奇亚 | 用于改善大脑的合生素组合物 |
| US20150320780A1 (en) | 2012-12-14 | 2015-11-12 | Glycom A/S | Mixture of fucosylate lactoses |
| HK1215521A1 (zh) | 2012-12-18 | 2016-09-02 | Abbott Laboratories | 包含神经保护膳食寡糖的营养组合物 |
| US20160113952A1 (en) * | 2013-05-22 | 2016-04-28 | Glycom As | Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal |
| US9902984B2 (en) | 2013-09-06 | 2018-02-27 | Glycom A/S | Fermentative production of oligosaccharides |
| RU2016123515A (ru) * | 2013-11-15 | 2017-12-20 | Нестек С.А. | Композиции для применения в целях профилактики или лечения некротизирующего энтероколита у детей грудного и младшего возраста |
| EP3068404B1 (en) | 2013-11-15 | 2021-01-06 | Société des Produits Nestlé S.A. | Compositions for use in the prevention or treatment of urt infections in infants or young children at risk |
| MX2016006221A (es) | 2013-11-15 | 2016-08-08 | Nestec Sa | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. |
| AU2014350146A1 (en) | 2013-11-15 | 2016-04-07 | Nestec S.A. | Infant formulas containing a 2-fucosylated oligosaccharide for treatment or prevention of influenza infection |
| ES2912278T3 (es) * | 2013-11-15 | 2022-05-25 | Nestle Sa | Composiciones para su uso en la prevención o el tratamiento de la enterocolitis necrosante en lactantes o niños pequeños nacidos por cesárea |
| EP2888950A1 (en) | 2013-12-24 | 2015-07-01 | Abbott Laboratories | Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment |
| US20170202864A1 (en) * | 2014-07-21 | 2017-07-20 | Abbott Laboratories | Nutrient delivery system with human milk oligosaccharides |
| US11040050B2 (en) * | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| US11040049B2 (en) * | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| ES2960750T3 (es) * | 2015-03-05 | 2024-03-06 | Glycom As | Oligosacáridos de la leche humana para el tratamiento de infecciones agudas del aparato respiratorio |
| US10751354B2 (en) * | 2015-09-14 | 2020-08-25 | Glycom A/S | Synthetic composition for microbiota modulation |
| PT3389404T (pt) | 2015-12-15 | 2020-01-14 | Nestle Sa | Mistura de hmos |
| US11278558B2 (en) * | 2017-03-01 | 2022-03-22 | Glycom A/S | Synthetic composition for microbiota modulation |
| AU2018265066B2 (en) | 2017-05-09 | 2023-10-19 | Societe Des Produits Nestle S.A. | Synergistic production of butyrate associated with the complexity of HMOs blend for use in infants or young children for health purposes |
-
2016
- 2016-12-15 PT PT168098515T patent/PT3389404T/pt unknown
- 2016-12-15 US US16/062,598 patent/US11432578B2/en active Active
- 2016-12-15 ES ES16809851T patent/ES2759556T3/es active Active
- 2016-12-15 CN CN202310049605.9A patent/CN116059221A/zh active Pending
- 2016-12-15 EP EP16809851.5A patent/EP3389404B1/en not_active Revoked
- 2016-12-15 BR BR112018010505-8A patent/BR112018010505B1/pt active IP Right Grant
- 2016-12-15 AU AU2016372446A patent/AU2016372446B2/en active Active
- 2016-12-15 US US16/061,424 patent/US11957148B2/en active Active
- 2016-12-15 WO PCT/IB2016/057675 patent/WO2017103850A1/en not_active Ceased
- 2016-12-15 EP EP16875027.1A patent/EP3389668A4/en active Pending
- 2016-12-15 MX MX2018007124A patent/MX377225B/es active IP Right Grant
- 2016-12-15 CN CN201680073344.2A patent/CN108541221B/zh active Active
- 2016-12-15 MY MYPI2018701602A patent/MY186217A/en unknown
- 2016-12-15 CN CN201680068659.8A patent/CN108289492A/zh active Pending
- 2016-12-15 WO PCT/EP2016/081308 patent/WO2017103019A1/en not_active Ceased
-
2018
- 2018-06-07 PH PH12018501221A patent/PH12018501221A1/en unknown
- 2018-06-11 CL CL2018001549A patent/CL2018001549A1/es unknown
- 2018-07-13 ZA ZA2018/04691A patent/ZA201804691B/en unknown
-
2021
- 2021-08-18 AU AU2021218066A patent/AU2021218066A1/en not_active Abandoned
-
2022
- 2022-09-06 US US17/929,905 patent/US12063949B2/en active Active
-
2024
- 2024-08-19 US US18/808,271 patent/US20240407419A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200260771A1 (en) | 2020-08-20 |
| EP3389668A1 (en) | 2018-10-24 |
| PT3389404T (pt) | 2020-01-14 |
| WO2017103019A1 (en) | 2017-06-22 |
| ZA201804691B (en) | 2020-07-29 |
| EP3389404A1 (en) | 2018-10-24 |
| CN108541221A (zh) | 2018-09-14 |
| PH12018501221A1 (en) | 2019-01-28 |
| US20240407419A1 (en) | 2024-12-12 |
| BR112018010505A2 (pt) | 2018-11-13 |
| US11432578B2 (en) | 2022-09-06 |
| RU2018125567A (ru) | 2020-01-16 |
| US20230000127A1 (en) | 2023-01-05 |
| AU2016372446B2 (en) | 2021-05-20 |
| US12063949B2 (en) | 2024-08-20 |
| US20180368460A1 (en) | 2018-12-27 |
| ES2759556T3 (es) | 2020-05-11 |
| US11957148B2 (en) | 2024-04-16 |
| CN116059221A (zh) | 2023-05-05 |
| WO2017103850A1 (en) | 2017-06-22 |
| CN108289492A (zh) | 2018-07-17 |
| MY186217A (en) | 2021-06-30 |
| AU2021218066A1 (en) | 2021-09-09 |
| CL2018001549A1 (es) | 2018-08-03 |
| CN108541221B (zh) | 2023-02-28 |
| EP3389668A4 (en) | 2019-08-21 |
| EP3389404B1 (en) | 2019-10-02 |
| BR112018010505B1 (pt) | 2021-11-16 |
| MX2018007124A (es) | 2018-09-07 |
| RU2018125567A3 (es) | 2020-04-13 |
| AU2016372446A1 (en) | 2018-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX377225B (es) | Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene. | |
| PH12021551077A1 (en) | A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier | |
| PH12017550040A1 (en) | Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children | |
| MX2016006220A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea. | |
| PH12018501325A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion | |
| MX2016006060A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. | |
| EP4508990A3 (en) | Compositions for use in improving stool consistency or frequency in infants or young children | |
| PH12021551071A1 (en) | A nutritional composition comprising 6`sl and lnt in combination to improve the gastrointestinal barrier function | |
| PH12016500610A1 (en) | Synthetic nutritional compositions especially adapted for male and female infants and young children | |
| PH12015502543A1 (en) | Anti-regurgitation composition maintaining gut motility | |
| PH12018501262A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies | |
| MX382069B (es) | Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños. | |
| PH12017500202A1 (en) | Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses | |
| PH12019500092A1 (en) | Nutritional compositions for infants and/or young children comprising oligosaccharides | |
| BR112017007362A2 (pt) | composições nutricionais compreendendo sn-1(3)-monoacilgliceróis para uso no tratamento de atrasos de crescimento em bebês ou crianças | |
| MX384125B (es) | Composiciones sintéticas de leche para infantes menores que tres meses de edad y para infantes y niños mayores que tres meses para asegurar el crecimiento óptimo y prevenir la obesidad. | |
| NZ753208A (en) | Anti-regurgitation composition maintaining gut motility | |
| TH157458A (th) | องค์ประกอบทางโภชนาการที่ถูกทำให้มีกลูตามีนมากขึ้นสำหรับทารกคลอดก่อนกำหนด |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. |
|
| FG | Grant or registration |